Vredenburgh J.J., Bohlin C., Reardon D.A., Desjardins A., Quinn J., Rich J., Sathornsumetee S., Marks L.B., Friedman A.H., Friedman H.S. Tinzaparin prophylaxis against thromboembolic complications in brain tumor patients. Journal of Clinical Oncology.
2006.
24
67S-67S.
Journal Name : Journal of Clinical Oncology Source : ISI
517.
Vredenburgh J.J., Desjardins A., Herndon J.E., Quinn J., Rich J., Sathornsumetee S., Friedman H.S., Reardon D., Gururangan S., Friedman A. Bevacizumab, a monoclonal antibody to vascular endothelial growth factor (VEGF), and irinotecan for treatment of malignant gliomas. Journal of Clinical Oncology.
2006.
24
59S-59S.
Journal Name : Journal of Clinical Oncology Source : ISI
518.
Wajcberg E., Triplitt C., Sriwijitkamol A., Defronzo R.A., Cersosimo E. Contribution of glucagon suppression to improved postprandial hyperglycemia induced by exenatide in patients with T2DM. Diabetes.
2006.
55
A28-A28.
Journal Name : Diabetes Source : ISI
519.
Wan J.M.F., Ngai H.H.Y., Sit W.H., Jiang P.P., Thongboonkerd V. Establishment of a 2-DE glomerular proteomic profile in membranous nephropathy. Molecular & Cellular Proteomics.
2006.
5
S120-S120.
Journal Name : Molecular & Cellular Proteomics Source : ISI
